Eduardo J. Ruiz
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway.
Journal: Frontiers in cell and developmental biology
Published: July 24, 2025
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.
Journal: Nature
Published: November 25, 2024
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
Journal: Cellular and molecular life sciences : CMLS
Published: September 27, 2021
PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway.
Journal: Frontiers in cell and developmental biology
Published: June 02, 2021
GREM1 is required to maintain cellular heterogeneity in pancreatic cancer.
Journal: Nature
Published: September 01, 2020
Geometric Affordance Perception: Leveraging Deep 3D Saliency With the Interaction Tensor.
Journal: Frontiers in neurorobotics
Published: October 13, 2019
ATMIN Is a Tumor Suppressor Gene in Lung Adenocarcinoma.
Journal: Cancer research
Published: February 22, 2019
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer.
Journal: JCI insight
Published: September 18, 2018
LUBAC determines chemotherapy resistance in squamous cell lung cancer.
Journal: The Journal of experimental medicine
Published: April 20, 2018
A paracrine network regulates the cross-talk between human lung stem cells and the stroma.
Journal: Nature communications
Published: August 16, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026